Women's health on wheels

June 05, 2001

On July 13, an 18-wheeler will leave Maryland, bound for the Navajo Indian Reservation in Arizona. On board will be an astonishing array of the latest in digital breast mammography equipment and sophisticated satellite systems for relaying the mammography images back to expert radiologists at the U.S. Army's Walter Reed Medical Center in Maryland and to Johns Hopkins in Baltimore.

It's all part of a high-tech initiative to demonstrate that state-of-the-art mammography screening and diagnosis can be made available to women in traditionally underserved regions and to determine the feasibility of extending the service to other underserved populations.

Conceived by Johns Hopkins, with support from the Walter Reed Army Medical Center, the Army Medical Research and Materiel Command and the Indian Health Service, the initial phase of the project was funded with a $250,000 grant from the Susan Komen Foundation. The initiative will bring real-time digital mammography to Navajo women along with training in breast self-examination and follow-up counseling.

Unlike conventional X-ray mammography, which requires films to be processed and printed, digital mammography produces visual results that can be viewed by technologists at the mobile center and relayed immediately via satellite to experts at Walter Reed and Hopkins. Based on the expert readings, the women can be informed if they need additional tests or procedures, such as diagnostic mammography or breast biopsies, while they are still at the center, helping ensure they receive prompt, effective follow-up care.

Another advantage of digital mammography is that it can reduce patient call-backs, an important consideration in remote or underserved areas. Call-backs occur when patients must return for imaging because of uncertainty over findings. With digital technology, doctors can enhance the digital image in a variety of ways with a computer, obtaining multiple views from a fewer number of images. As an added plus, digital mammography uses less radiation than conventional mammography.

The Mobile Breast Care Center will be dedicated on June 8, at 10 a.m. at The Johns Hopkins University Applied Physics Laboratory in Laurel, Md., where it has been undergoing tests. Attending the dedication will be representatives from The Johns Hopkins University School of Medicine, the Navajo Nation, the U.S. Army Medical Department, General Electric, the U.S. Department of Health and Human Services' Office of Women's Health and the Food and Drug Administration, and the Indian Health Service.

The mobile unit housing the mammography equipment stretches to 80 feet long and 40 feet wide when in operation, but retracts to a more manageable length of 53 feet and a width of 8 and a half feet when on the road. Within the van, sophisticated computer equipment and interfaces to a satellite telecommunications link provide high-speed transmission of images for interpretation within minutes. The GE mammography system, recently approved by the FDA, digitizes X-ray mammography images and displays them on a workstation for local viewing to assure image quality.

Image acquisition to display takes only seconds. Digitized images are then sent via satellite to experts at Walter Reed for interpretation and to Hopkins for quality assurance.

Breast cancer will affect one in eight women during their lifetimes and is the second leading cause of cancer death in women. Mammography cancer screening is one of the most important tools for detecting breast cancers early, when they are most responsive to treatment.

The Mobile Breast Care Center is especially important for Native American women, who often have limited access to breast cancer screening compared with many other women. A recent NIH study (Oct 13, 2000) reports that 4.9 percent of Native American women undergoing their first mammography screening for breast cancer are found to have suspicious findings in their breast.

"This project takes us to the patient, so that we can detect problems and treat them early on, when treatment is most effective," says Joseph Gitlin, Ph.D., associate professor of radiology at Hopkins, who spearheaded the design of the mobile digital telemammography project. "It also is designed to be a model for reaching other underserved groups of women. Once we prove the effectiveness of this approach to providing mammography services, we envision developing similar mobile units to reach women in other remote areas as well as women in urban settings who have limited access to breast cancer screening.

"The key to success is the immediacy of reporting the results of the examinations to the patients," says Lillie Shockney, director of Hopkins' Breast Cancer Outreach Program. "Immediate reports allow a woman to get counseling from experts who are there with her and to ask questions about getting treatment. This is especially important for many of these women, because they often don't have telephones and primary care physicians and tend to move frequently. The chances of a patient getting the appropriate care are greatly increased if she receives a report and counseling before she leaves the Mobile Breast Care Center."
Reporter's Note: Press wishing to attend the dedication should contact Gary Stephenson. The dedication will be held at The Johns Hopkins University Applied Physics Laboratory, 11100 Johns Hopkins Road, Laurel, Md., located one-half mile west of the intersection of Johns Hopkins Road and U.S. Route 29. Once at the Applied Physics Laboratory, follow signs to the dedication.

Media Contact: Gary Stephenson 410-955-5384, Email: gstephenson@jhmi.edu.

Johns Hopkins Medical Institutions' news releases are available on an EMBARGOED basis on EurekAlert at http://www.eurekalert.org Newswise at http://www.newswise.com and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkins@jhmi.edu.

On a POST-EMBARGOED basis find them at http://www.hopkinsmedicine.org and Quadnet at http://www.quad-net.com.

Johns Hopkins Medicine

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.